Clinical Trials · NCT05132088

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity

Name: Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Semaglutide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Novo Nordisk A/S
Enrollment: 201
Start date: Nov 2021
Locations: 15 sites, Japan, South Korea
Primary endpoint: Percent Change From Baseline in Body Weight

View Semaglutide compound reference